Cll Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia
Active, not recruiting
  • CLL
  • Vaccine Response
  • PCV13
  • PPSV23
  • Örebro, Sweden
    Magdalena Kättström
2022-03-29
Mar 29, 2022
S
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - 2020
Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
2022-04-04
Apr 4, 2022
U
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
    • Bobigny, France
    • +8 more
    2022-03-23
    Mar 23, 2022
    G
    A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.
    Recruiting
    • B Cell NHL
    • CLL
    • GB261
    • Melbourne, The State Of Victoria, Australia
    • +2 more
    2022-04-01
    Apr 1, 2022
    T
    Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia
    Recruiting
    • CLL
    • +9 more
    • TG-1801
    • Ublituximab
    • Fayetteville, Arkansas
    • +4 more
    2022-03-22
    Mar 22, 2022
    M
    A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Withdrawn
    • CLL
    • +4 more
    • Treatment Free Observation
    • Basking Ridge, New Jersey
    • +8 more
    2022-03-04
    Mar 4, 2022
    M
    Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) - 2022
    Completed
    • CLL
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2022-03-14
    Mar 14, 2022
    C
    A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors
    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    2022-03-07
    Mar 7, 2022
    T
    Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL) - 2010
    Completed
    • CLL
      • Tampere, Finland
        Tampere university Hospital
      2022-02-22
      Feb 22, 2022
      M
      Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL
      Not yet recruiting
      • CLL
      • (no location specified)
      2022-02-08
      Feb 8, 2022
      D
      Hypertension Management in Cancer Patients
      Suspended
      • Blood Pressure
      • +6 more
      • Automated Messaging
      • Durham, North Carolina
        Duke University Medical Center
      2022-01-21
      Jan 21, 2022
      U
      Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
      Recruiting
      • CLL
      • B-cell Non Hodgkin Lymphoma
      • New Haven, Connecticut
      • +2 more
      2022-01-07
      Jan 7, 2022
      G
      Registry of the German CLL Study Group
      Recruiting
      • CLL
      • +7 more
        • Dresden, Sachsen, Germany
          BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
        2021-12-16
        Dec 16, 2021
        G
        Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients
        Recruiting
        • CLL
        • Chronic Lymphocytic Leukemia
        • Peripheral blood samples withdrawal
        • Milano, Italy
        • +1 more
        2022-01-03
        Jan 3, 2022
        N
        Haploidentical Stem Cell Transplant With Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
        Active, not recruiting
        • Multiple Myeloma
        • +4 more
        • Total Body Irradiation
        • +5 more
        • Los Angeles, California
          Cedars Sinai Medical Center
        2021-12-01
        Dec 1, 2021
        V
        Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL - 2021
        Withdrawn
        • Chronic Lymphocytic Leukemia
        • +8 more
        • Dose combination 1-1
        • +5 more
        • (no location specified)
        2021-11-01
        Nov 1, 2021
        M
        A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
        Active, not recruiting
        • CLL
        • Standard of Care
        • Buenos Aires, Argentina
          Fundaleu
        2021-10-15
        Oct 15, 2021
        U
        Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
        Active, not recruiting
        Has Results
        • Chronic Lymphocytic Leukemia
        • CLL
        • La Jolla, California
          University of California, San Diego
        2021-09-02
        Sep 2, 2021
        R
        Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment
        Recruiting
        • CLL
        • Copenhagen, Denmark
        • +5 more
        2021-09-17
        Sep 17, 2021
        U
        A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)
        Active, not recruiting
        • CLL
        • La Jolla, California
          UCSD Moores Cancer Center
        2021-09-02
        Sep 2, 2021
        S
        CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.
        Active, not recruiting
        • CLL
        • ibrutinib, venetoclax, obinutuzumab
        • ibrutinib, venetoclax
        • Aalborg, Denmark
        • +26 more
        2021-08-20
        Aug 20, 2021
        T
        The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
        Active, not recruiting
        • CLL
        • +2 more
          • Tel Aviv, Israel
            Tel-Aviv Sourasky Medical Center
          2021-08-08
          Aug 8, 2021
          G
          Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL - 2013
          Completed
          • NHL
          • +17 more
          • veltuzumab
          • Savannah, Georgia
          • +4 more
          2021-08-12
          Aug 12, 2021
          M
          A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue - 2020
          Completed
          Has Results
          • Leukemia
          • CLL
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          2021-06-30
          Jun 30, 2021
          A
          ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
          Active, not recruiting
          • Follicular Lymphoma (FL)
          • +12 more
          • Tucson, Arizona
          • +18 more
          2021-06-17
          Jun 17, 2021